Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study.
Weill A, Delyon J, Descamps V, Deschamps L, Dinulescu M, Dupuy A, Célérier P, Nardin C, Aubin F, Le Corre Y, Heidelberger V, Maubec E, Malissen N, Longvert C, Machet L, Gounant V, Brosseau S, Bonniaud B, Jeudy G, Psimaras D, Doucet L, Lebbe C, Zalcman G, De Masson A, Baroudjian B, Leonard-Louis S, Hervier B, Brunet-Possenti F; Groupe de Cancérologie Cutanée and PATIO Group.
Weill A, et al. Among authors: nardin c.
Rheumatology (Oxford). 2021 Dec 1;60(12):5753-5764. doi: 10.1093/rheumatology/keab249.
Rheumatology (Oxford). 2021.
PMID: 33725115